These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2538202)

  • 1. Calcium channel antagonist receptors in cerebral cortex from alcoholic patients.
    Marks SS; Watson DL; Carpenter CL; Messing RO; Greenberg DA
    Brain Res; 1989 Jan; 478(1):196-8. PubMed ID: 2538202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical dihydropyridine binding sites are unaltered in human alcoholic brain.
    Kril JJ; Gundlach AL; Dodd PR; Johnston GA; Harper CG
    Ann Neurol; 1989 Sep; 26(3):395-7. PubMed ID: 2529812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of chronic exposure to ethanol and calcium channel antagonists on calcium channel antagonist receptors in cultured neural (PC12) cells.
    Marks SS; Watson DL; Carpenter CL; Messing RO; Greenberg DA
    J Neurochem; 1989 Jul; 53(1):168-72. PubMed ID: 2470859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C participates in up-regulation of dihydropyridine-sensitive calcium channels by ethanol.
    Messing RO; Sneade AB; Savidge B
    J Neurochem; 1990 Oct; 55(4):1383-9. PubMed ID: 2168938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110.
    Borsotto M; Barhanin J; Norman RI; Lazdunski M
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1357-66. PubMed ID: 6089781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel agonist and antagonist binding in a highly enriched sarcolemma preparation obtained from canine ventricle.
    Rampe D; Poder T; Zhao ZY; Schilling WP
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):547-56. PubMed ID: 2470991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental changes of the distribution of binding sites for organic Ca2+-channel blockers in cat visual cortex.
    Bode-Greuel KM; Singer W
    Exp Brain Res; 1988; 70(2):266-75. PubMed ID: 2838315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydropyridine receptor binding sites in the cardiomyopathic hamster heart are unchanged from control.
    Bazan E; Sole MJ; Schwartz A; Johnson CL
    J Mol Cell Cardiol; 1991 Feb; 23(2):111-7. PubMed ID: 1648625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+)-[3H]-PN 200-110 binding to cell membranes and intact strips of portal vein smooth muscle: characterization and modulation by membrane potential and divalent cations.
    Dacquet C; Loirand G; Rakotoarisoa L; Mironneau C; Mironneau J
    Br J Pharmacol; 1989 May; 97(1):256-62. PubMed ID: 2524235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of the cardiac 1,4-dihydropyridine receptor/calcium channel complex.
    Rengasamy A; Ptasienski J; Hosey MM
    Biochem Biophys Res Commun; 1985 Jan; 126(1):1-7. PubMed ID: 2982362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonist drug selectivity for radioligand binding sites on voltage-gated and N-methyl-D-aspartate receptor-gated Ca2+ channels.
    Jaffe DB; Marks SS; Greenberg DA
    Neurosci Lett; 1989 Oct; 105(1-2):227-32. PubMed ID: 2562062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depolarization of chick myotubes triggers the appearance of (+)-[3H]PN 200-110-binding sites.
    Pauwels PJ; Van Assouw HP; Leysen JE
    Mol Pharmacol; 1987 Dec; 32(6):785-91. PubMed ID: 2826992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of (+)-PN 200-110 to rat pituitaries and to normal and adenomatous human pituitaries.
    Bression D; Chaumet-Riffaud P; Brandi AM; Comte A; Peillon F; Kiechel JR
    Mol Cell Endocrinol; 1987 Apr; 50(3):255-61. PubMed ID: 3032711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Ca2+ antagonists binding protein from cytosolic fraction the precursor of alpha 1-subunit of Ca2+ channel?
    Krizanová O; Hudecová S; Orlický J; Zachar J
    Gen Physiol Biophys; 1989 Apr; 8(2):99-111. PubMed ID: 2550315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The failure of endothelin to displace bound, radioactively-labelled, calcium antagonists (PN 200/110, D888 and diltiazem).
    Gu XH; Liu JJ; Dillon JS; Nayler WG
    Br J Pharmacol; 1989 Feb; 96(2):262-4. PubMed ID: 2538185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel receptor sites for (+)-[3H]PN 200-110 in coronary artery.
    Yamada S; Kimura R; Harada Y; Nakayama K
    J Pharmacol Exp Ther; 1990 Jan; 252(1):327-32. PubMed ID: 2153804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal calcium channel antagonist receptors in Huntington's disease and Parkinson's disease.
    Watson DL; Carpenter CL; Marks SS; Greenberg DA
    Ann Neurol; 1988 Mar; 23(3):303-5. PubMed ID: 2967667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltage-dependent binding of dihydropyridine calcium channel blockers to guinea pig ventricular myocytes.
    Kamp TJ; Sanguinetti MC; Miller RJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1240-7. PubMed ID: 2849670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoaffinity labeling of the calcium channel antagonist receptor in the heart of the cardiomyopathic hamster.
    Kuo TH; Johnson DF; Tsang W; Wiener J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):926-33. PubMed ID: 2446613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.